Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jan 2018. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3753010015 | Prostaglandin-endoperoxide synthase isoform 2 inhibitor | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 3753726011 | Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 3753727019 | COX-2 inhibitor | en | Synonym | Active | Entire term case sensitive | SNOMED CT core module |
| 3753728012 | PTGS-2 inhibitor | en | Synonym | Active | Entire term case sensitive | SNOMED CT core module |
| 3753729016 | Cyclooxygenase-2 inhibitor | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | Is a | Non-steroidal anti-inflammatory agent | true | Inferred relationship | Existential restriction modifier | ||
| Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | Is a | Substance with enzyme inhibitor mechanism of action | false | Inferred relationship | Existential restriction modifier | ||
| Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | Has disposition | Prostaglandin-endoperoxide synthase isoform 2 inhibitor | true | Inferred relationship | Existential restriction modifier | ||
| Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | Is a | Substance with prostaglandin-endoperoxide synthase inhibitor mechanism of action (substance) | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing etodolac | Has active ingredient | False | Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | Inferred relationship | Existential restriction modifier | |
| Product containing prostaglandin-endoperoxide synthase isoform 2 inhibitor (product) | Has active ingredient | True | Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | Inferred relationship | Existential restriction modifier | 1 |
| Product containing precisely etodolac 200 milligram/1 each conventional release oral capsule | Has active ingredient | False | Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | Inferred relationship | Existential restriction modifier | |
| Product containing precisely etodolac 300 milligram/1 each conventional release oral capsule | Has active ingredient | False | Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | Inferred relationship | Existential restriction modifier | |
| Etodolac 600mg m/r tablet | Has active ingredient | False | Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | Inferred relationship | Existential restriction modifier | |
| Product containing precisely celecoxib 200 milligram/1 each conventional release oral capsule | Has active ingredient | False | Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | Inferred relationship | Existential restriction modifier | |
| Product containing precisely celecoxib 100 milligram/1 each conventional release oral capsule | Has active ingredient | False | Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | Inferred relationship | Existential restriction modifier | |
| Product containing celecoxib | Has active ingredient | False | Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | Inferred relationship | Existential restriction modifier | |
| Etodolac 500mg m/r tablet | Has active ingredient | False | Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | Inferred relationship | Existential restriction modifier | |
| Etodolac 400mg m/r tablet | Has active ingredient | False | Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | Inferred relationship | Existential restriction modifier | |
| Product containing precisely etodolac 400 milligram/1 each conventional release oral tablet | Has active ingredient | False | Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | Inferred relationship | Existential restriction modifier | |
| Product containing precisely etodolac 500 milligram/1 each conventional release oral tablet | Has active ingredient | False | Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | Inferred relationship | Existential restriction modifier | |
| Product containing valdecoxib | Has active ingredient | False | Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | Inferred relationship | Existential restriction modifier | |
| Product containing precisely valdecoxib 10 milligram/1 each conventional release oral tablet | Has active ingredient | False | Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | Inferred relationship | Existential restriction modifier | |
| Product containing precisely valdecoxib 20 milligram/1 each conventional release oral tablet | Has active ingredient | False | Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | Inferred relationship | Existential restriction modifier | |
| Nabumetone | Is a | True | Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | Inferred relationship | Existential restriction modifier | |
| Rofecoxib | Is a | True | Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | Inferred relationship | Existential restriction modifier | |
| Meloxicam | Is a | True | Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | Inferred relationship | Existential restriction modifier | |
| Product containing parecoxib | Has active ingredient | False | Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | Inferred relationship | Existential restriction modifier | |
| Parecoxib 40mg injection (pdr for recon) | Has active ingredient | False | Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | Inferred relationship | Existential restriction modifier | |
| Parecoxib 40mg injection (pdr for recon)+diluent | Has active ingredient | False | Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | Inferred relationship | Existential restriction modifier | |
| Product containing etoricoxib | Has active ingredient | False | Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | Inferred relationship | Existential restriction modifier | |
| Etoricoxib 60mg tablet | Has active ingredient | False | Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | Inferred relationship | Existential restriction modifier | |
| Etoricoxib 90mg tablet | Has active ingredient | False | Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | Inferred relationship | Existential restriction modifier | |
| Etoricoxib 120mg tablet | Has active ingredient | False | Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | Inferred relationship | Existential restriction modifier | |
| Product containing precisely etoricoxib 60 milligram/1 each conventional release oral tablet | Has active ingredient | False | Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | Inferred relationship | Existential restriction modifier | |
| Product containing precisely etoricoxib 90 milligram/1 each conventional release oral tablet | Has active ingredient | False | Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | Inferred relationship | Existential restriction modifier | |
| Product containing precisely etoricoxib 120 milligram/1 each conventional release oral tablet | Has active ingredient | False | Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | Inferred relationship | Existential restriction modifier | |
| Parecoxib 40mg injection (pdr for recon) | Has active ingredient | False | Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | Inferred relationship | Existential restriction modifier | |
| Parecoxib 40mg injection (pdr for recon)+diluent | Has active ingredient | False | Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | Inferred relationship | Existential restriction modifier | |
| Product containing precisely valdecoxib 40 milligram/1 each conventional release oral tablet | Has active ingredient | False | Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | Inferred relationship | Existential restriction modifier | |
| Celecoxib | Is a | True | Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | Inferred relationship | Existential restriction modifier | |
| Etoricoxib | Is a | True | Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | Inferred relationship | Existential restriction modifier | |
| Parecoxib | Is a | True | Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | Inferred relationship | Existential restriction modifier | |
| Valdecoxib | Is a | True | Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | Inferred relationship | Existential restriction modifier | |
| Deracoxib | Is a | True | Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | Inferred relationship | Existential restriction modifier | |
| Firocoxib | Is a | True | Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | Inferred relationship | Existential restriction modifier | |
| Lumiracoxib | Is a | True | Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | Inferred relationship | Existential restriction modifier | |
| Nimesulide | Is a | True | Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | Inferred relationship | Existential restriction modifier | |
| Parecoxib sodium | Is a | True | Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | Inferred relationship | Existential restriction modifier | |
| Ketorolac trometamol | Is a | True | Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | Inferred relationship | Existential restriction modifier | |
| Ketorolac | Is a | True | Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | Inferred relationship | Existential restriction modifier | |
| Etodolac | Is a | True | Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | Inferred relationship | Existential restriction modifier | |
| Nepafenac | Is a | True | Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | Inferred relationship | Existential restriction modifier | |
| Ibuprofen sodium | Is a | True | Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | Inferred relationship | Existential restriction modifier | |
| Ibuprofen | Is a | True | Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | Inferred relationship | Existential restriction modifier | |
| Ibuprofen sodium dihydrate | Is a | True | Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | Inferred relationship | Existential restriction modifier | |
| Ibuprofen lysine | Is a | True | Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | Inferred relationship | Existential restriction modifier | |
| Dexibuprofen | Is a | True | Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | Inferred relationship | Existential restriction modifier | |
| Dexketoprofen trometamol | Is a | True | Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | Inferred relationship | Existential restriction modifier | |
| Dexketoprofen | Is a | True | Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | Inferred relationship | Existential restriction modifier | |
| Naproxen sodium | Is a | True | Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | Inferred relationship | Existential restriction modifier | |
| Naproxen | Is a | True | Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | Inferred relationship | Existential restriction modifier | |
| Fenoprofen | Is a | True | Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | Inferred relationship | Existential restriction modifier | |
| Fenoprofen calcium | Is a | True | Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | Inferred relationship | Existential restriction modifier | |
| Alminoprofen | Is a | True | Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | Inferred relationship | Existential restriction modifier | |
| Etodolac 200mg capsule - product | Has active ingredient | False | Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | Inferred relationship | Existential restriction modifier | |
| Etodolac 200mg tablet | Has active ingredient | False | Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | Inferred relationship | Existential restriction modifier | |
| Etodolac 300mg capsule - product | Has active ingredient | False | Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | Inferred relationship | Existential restriction modifier | |
| Etodolac 600mg m/r tablet - product | Has active ingredient | False | Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | Inferred relationship | Existential restriction modifier | |
| Celecoxib 100mg capsule - product | Has active ingredient | False | Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | Inferred relationship | Existential restriction modifier | |
| Celecoxib 200mg capsule - product | Has active ingredient | False | Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | Inferred relationship | Existential restriction modifier | |
| Arcoxia 60mg tablet | Has active ingredient | False | Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | Inferred relationship | Existential restriction modifier | |
| Arcoxia 90mg tablet | Has active ingredient | False | Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | Inferred relationship | Existential restriction modifier | |
| Arcoxia 120mg tablet | Has active ingredient | False | Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | Inferred relationship | Existential restriction modifier | |
| Dynastat 40mg injection (pdr for recon) | Has active ingredient | False | Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | Inferred relationship | Existential restriction modifier | |
| Dynastat 40mg injection (pdr for recon)+diluent | Has active ingredient | False | Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | Inferred relationship | Existential restriction modifier | |
| Valdecoxib | Has active ingredient | False | Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | Inferred relationship | Existential restriction modifier | |
| Lodine 200mg tablet | Has active ingredient | False | Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | Inferred relationship | Existential restriction modifier | |
| Lodine 200mg capsule | Has active ingredient | False | Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | Inferred relationship | Existential restriction modifier | |
| Lodine 300mg capsule | Has active ingredient | False | Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | Inferred relationship | Existential restriction modifier | |
| Lodine SR 600mg m/r tablet | Has active ingredient | False | Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | Inferred relationship | Existential restriction modifier | |
| Ramodar 200mg tablet | Has active ingredient | False | Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | Inferred relationship | Existential restriction modifier | |
| Celebrex 100mg capsule | Has active ingredient | False | Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | Inferred relationship | Existential restriction modifier | |
| Celebrex 200mg capsule | Has active ingredient | False | Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | Inferred relationship | Existential restriction modifier | |
| Ebretin 200mg capsule | Has active ingredient | False | Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | Inferred relationship | Existential restriction modifier | |
| Ebretin 300mg capsule | Has active ingredient | False | Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | Inferred relationship | Existential restriction modifier | |
| Eccoxolac 300mg capsule | Has active ingredient | False | Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | Inferred relationship | Existential restriction modifier | |
| Valdecoxib 10mg tablet | Has active ingredient | False | Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | Inferred relationship | Existential restriction modifier | |
| Valdecoxib 40mg tablet | Has active ingredient | False | Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | Inferred relationship | Existential restriction modifier | |
| Valdecoxib 20mg tablet | Has active ingredient | False | Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | Inferred relationship | Existential restriction modifier | |
| Bextra 10mg tablet | Has active ingredient | False | Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | Inferred relationship | Existential restriction modifier | |
| Bextra 20mg tablet | Has active ingredient | False | Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | Inferred relationship | Existential restriction modifier | |
| Bextra 40mg tablet | Has active ingredient | False | Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | Inferred relationship | Existential restriction modifier | |
| Lumiracoxib | Has active ingredient | False | Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR